Historical background
In 1967 two Australian chest physicians drew attention to the importance of arterial blood gas abnormalities in 12 patients with status asthmaticus (acute severe asthma) and in 64 others with clinically less severe disease.' They documented that in many patients with asthma arterial blood gas abnormalities were commonly present, usually mild to moderate hypoxaemia. Likewise they outlined that, even when this fall in Pao2 was insufficient to induce life threatening hypoxaemia, it rendered patients more vulnerable to effects from any further increase in airways obstruction. Even though there was a correlation between the reduction in forced expiratory volume in one Normal second (FEVI) and the extent of arterial blood gas abnormalities, FEVy levels >10 litres were not a reliable predictor of the Pao2. One year later McFadden and Lyons2 confirmed these results in 101 patients suffering an acute exacerbation of asthma, in whom arterial hypoxaemia was present in most; hypercapnia was less common and not observed until airway obstruction became severe. Subsequently McFadden et al3 postulated that obstructive changes in peripheral airways could be a factor that might explain why patients with acute severe asthma show refractoriness to standard treatment with bronchodilators or relapse after hospital discharge, or both. In all these studies the most likely mechanism of arterial VA/Q ratio Figure 2 Sequential VAIQ ratio distributions in a representative patient with acute severe asthma in hospital (days I and 5), at discharge, and one month thereafter. The characteristic bimodal blood flow pattern shown at day 1 was still present, although more modestly, at day 5, to become broadly unimodal at discharge. One month later both distributions were narrowly unimodal, similar to a healthy individual. Shunt (0) was always absent and dead space (not shown) was normal. Reproduced from ref 15 with permission.
hypoxaemia was considered to be ventilationperfusion (VA/Q) abnormalities, attributed mainly to an increased physiological dead space, although an additional small shunt effect was evident among the most affected patients. All in all, despite the general acknowledgement that VA/Q inequality was the major cause of hypoxaemia, little information had been collected on the VA/Q relationships in patients with asthma and their modification by different interventions.
Over the last 15 years a large body ofevidence on pulmonary gas exchange in bronchial asthma has been collected using the multiple inert gas elimination technique (MIGET).4 This article reviews the characteristics of the principal mechanisms of pulmonary gas exchange in the different clinical forms of bronchial asthma in adults and their potential relation with structural changes. The effects of breathing high oxygen concentrations and the response to some of the current bronchodilator agents will also be discussed to shed further light on the mechanisms of abnormal gas exchange in asthma. This may help the clinician in the interpretation of the complex interplay between the intrapulmonary (essentially VA/Q mismatching) and extrapulmonary (overall The original study using MIGET was by Wagner et al7 in asymptomatic patients with long standing mild to moderate asthma, none having required medical attention for at least one month before the study. All but one patient had a normal or slightly reduced Pao2. The most novel finding was the presence of a clearcut bimodal pattern in the blood flow distribution, with shunt and areas of high VA/Q ratios conspicuously absent or trivial, and a normal dead space. This bimodal blood flow pattern included a large fraction of cardiac output associated with the mode of reduced VA/Q regions, in which ventilation is decreased but perfusion remains unaffected. The extent ofVA/ Q inequality and the prevalence of the bimodal blood flow pattern was greater in this early study than in later series studying patients with mild to moderate asthma.-" Several reasons, including differences in patient selection, their clinical management and treatment, could have accounted for the apparent conflict between the first study7 and those that showed less VA/Q mismatch, despite similar airways obstruction. 8-" In one of the studies Wagner et al8 assessed the prevalence and variability of VA/Q distributions in stable, symptomatic patients (mean FEV, 72% predicted) once a week for two months. The patients were taking regular mainly related to events occurring in the distal, small airways. A further study'7 which assessed possible differences in the time course and severity of airway obstruction and VA/Q inequality in patients with acute severe asthma according to whether admitted or discharged home reinforces this concept. As expected, on admission airflow rates and indices of gas exchange were significantly lower in those patients admitted than in those sent home. However, while in the former patients spirometric changes recovered more rapidly and efficiently than VA/Q abnormalities, the time course of the two indices of lung function measurements in the latter group was similar (fig 4) . From a pathophysiological viewpoint it can be postulated that patients sent home had fewer airway inflammatory changes and recovered more rapidly with treatment than those admitted, who in turn needed longer to recover their overall lung function. Lagerstrand et al2' have shown that VA/Q abnormalities similar to those observed in human asthma can be clearly seen when small droplets of isotonic saline are nebulised in a rabbit model with no increase in total inspiratory resistance.
We have recently shown that, in patients with mild asthma22 and in healthy individuals,23 the inhalation of platelet activating factor (PAF), a potent mediator of inflammation, provoked VA/Q mismatch similar to that shown in patients with moderate to severe forms of asthma. It was suggested that these gas exchange abnormalities induced by PAF were more related to airway microvascular leakage than to bronchoconstriction by itself. These data would support the concept that endogenous release of PAF may be connected with the altered arterial blood gases shown during acute exacerbations of asthma.
Structure and functional correlations Bronchial asthma is a disease in which active bronchoconstriction, together with airway inflammation, hyperaemia, inspissated mucus, mucus impaction, and bronchial wall oedema may all lead to the occlusion of peripheral airways.24 The alveolar units distal to these narrowed airways may therefore be only minimally ventilated, even in severe acute attacks, by collateral pathways from relatively unaffected neighbouring alveoli, thus precluding the development of completely unventilated alveolar units (shunt) . This obstruction produces areas of low VA/Q regions that remain perfused but poorly ventilated. From a simple numerical viewpoint this must increase blood flow dispersion (log SDQ) more than ventilation dispersion (log SDv). Further, the presence of minimal or no shunt suggests that the occlusion of the airways is never functionally complete, and that the role of hypoxic pulmonary vasoconstriction is exceptionally efficient.
These features could account for the broadly unimodal or bimodal patterns of VA/Q dependent on the clinical state of each patient. In chronic severe asthma it may be that the airway narrowing caused by inflammation occurs predominantly in the more distal airways producing a broadly unimodal blood flow profile.'2"" In contrast, in acute severe asthma the inflammatory process may extend more centrally, resulting in a bimodal pattern of pulmonary perfusion. '5-18 In postmortem lung studies from patients with sudden fatal asthma bronchioles were occluded, there was increase in thickness of the smooth muscle, and an inflammatory infiltrate with both mononuclear cells and eosinophils. 25 Although muscular pulmonary arteries adjacent to occluded and inflamed small airways did not show morphological features of chronic hypoxia, they did have considerable inflammatory changes in their walls which were most noticeable when close to peripheral airways. In spite of the fact that the precise functional significance of this vascular involvement still remains uncertain, the structural findings shown in peripheral airways in these patients support our contention that small airway occlusion constitutes the morphological basis of gas exchange abnormalities found in acute asthma. [15] [16] [17] [18] Effects of breathing oxygen Given that VA/Q mismatching is the principal determinant of the low Pao2 in asthma, a clinical consequence of practical interest is that arterial hypoxaemia can be rapidly and efficiently reversed by moderate increases in inspired oxygen concentration -that is, between 024 and 040. When breathing 100% oxygen the effects of gas exchange remain similar irrespective of the clinical type of asthma. Specifically, VA/Q mismatch substantially worsens: the index of blood flow dispersion (log SDQ) always increases significantly. This occurs both in patients with acute severe asthma'618 and also in those with chronic severe asthma.'213 Corte and Young'2 showed in a few patients with chronic asthma that the inert gas variables remained unaltered during oxygen breathing in those with more abnormal baseline VA/Q distributions, suggesting that these patients had more distal airway involvement. An increase of the log SDQ, with or without the development of areas with poorly ventilated VA/Q ratios, while breathing 100% oxygen suggests that hypoxic pulmonary vasoconstriction is reduced even in the absence of pulmonary haemodynamic changes.
In patients with status asthmaticus requiring mechanical support neither the pulmonary arterial pressure nor the cardiac output changed significantly when breathing 100% oxygen. '8 At first glance this suggests the absence of a pulmonary vascular response to oxygen. Yet the log SDQ increased significantly. Using the mechanisms of vascular recruitment and dilatation, the pulmonary circulation may redistribute blood flow without altering standard flow-pressure relationships but still induces significant changes in some of the most common markers ofVA/Q inequalities. Similar data have been reported in patients with COPD2627 or cryptogenic fibrosing alveolitis. 28 Furthermore, patients with critical life threatening status asthmaticus on mechanical sup-port displayed an additional important finding: the development ofmoderate amounts ofshunt (mean 8-3% of cardiac output) while breathing 100% oxygen,'8 a rare finding in patients with chronic respiratory disease.'4 Indeed, those with acute lung injury develop a significant increase in shunt (on average 30%) when breathing 100% oxygen.29 The development of shunt could be explained by collateral ventilation becoming insufficient whilst breathing oxygen, causing collapse of alveolar units with critical inspiratory VA/Q ratios30 and, ultimately, reabsorption atelectasis. Similarly, the possibility that breathing oxygen relaxes the vascular tone of already completely unventilated (atelectatic) areas at baseline inspired oxygen conditions, thereby increasing the perfusion ofthese small pre-existing shunts, may be an additional factor to be considered. This would increase shunt without the need for further reabsorption atelectasis.
In contrast, the effects of 100% oxygen on the log SDv were less uniform than those observed on the log SDQ. Thus, while the former variable increased (worsened) significantly in patients with acute severe asthma breathing spontaneously '6 while inducing a similar degree of airway bronchodilatation to inhaled salbutamol; heart rate, cardiac output, and oxygen uptake also increased substantially. '6 We have suggested that both nebulised salbutamol and adrenaline in a canine model of asthma upset pulmonary gas exchange less than isoprenaline.35 Although it is not possible to differentiate between an increase in cardiac output causing an increase in the dispersion of blood flow or a reduction in the pulmonary vascular tone, or both, it seems reasonable to ascribe the further VA/Q deterioration following intravenous salbutamol to the relevant associated cardiovascular and metabolic effects of the drug, probably due to higher plasma levels. In an experimental model of bronchoconstriction after methacholine Wagner et al36 have suggested that aggravation of VA/Q relationships with an increase in cardiac output depends more on the pulmonary vascular tone of uninjured areas than on those regions with VA/Q mismatching.
Further worsening or lack of improvement in VA/Q mismatch after airflow rates have returned to normal following bronchodilators is one of the most provocative findings ever seen in asthma. However, this observation concurs with our hypothesis that VA/Q mismatch in asthma is related more to abnormalities in peripheral airways, and airflow rates essentially reflect more central airways obstruction. [15] [16] [17] From a clinical viewpoint, however, some conclusions can be drawn. Although hypoxaemia associated with the use of bronchodilators at therapeutic levels does not seem to represent a serious side effect, clinicians should (1) be aware that hypoxaemia may occur after use of bronchodilators depending on the dose and mode of administration and the clinical characteristics of each patient; (2) realise that substantial VA/Q mismatching may occur with little change, if any, in Pao2, and (3) remember that changes in total ventilation, cardiac output, and oxygen consumption may play a pivotal part in determining overall gas exchange, quite separate from those due to inspired oxygen concentration by itself.
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